07/28/2025 10:38 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) Iroquois Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
07/21/2025 10:16 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
07/16/2025 3:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2025 8:18 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B4 | |
07/15/2025 11:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form EFFECT | |
07/10/2025 4:29 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1/A | |
07/09/2025 12:05 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1/A | |
07/08/2025 3:46 PM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject)
| Form FWP | |
07/08/2025 3:08 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
06/18/2025 7:27 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2025 3:34 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for BCTXW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
05/13/2025 8:08 PM | 3i, LP (Filed by) BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/01/2025 9:01 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G | |
04/28/2025 3:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/28/2025 8:06 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B4 | |
04/28/2025 8:07 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B4 | |
04/24/2025 11:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form EFFECT | |
04/24/2025 4:11 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1MEF | |
04/24/2025 3:41 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form CERT | |
04/24/2025 2:46 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-A12B | |
04/23/2025 3:51 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form S-1/A | |
04/22/2025 3:26 PM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject)
| Form FWP | |
02/10/2025 8:02 PM | 3i, LP (Filed by) BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/06/2025 3:30 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2025 4:02 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2025 3:05 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
02/03/2025 3:37 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
12/17/2024 3:05 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form DEF 14A | |
12/13/2024 3:15 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2024 4:27 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
12/12/2024 5:06 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
12/11/2024 4:21 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
12/10/2024 5:06 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
12/05/2024 6:45 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
11/14/2024 11:17 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SC 13G/A | |
11/01/2024 3:05 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2024 9:12 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 424B5 | |
10/01/2024 3:02 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/16/2024 9:22 AM | BriaCell Therapeutics Corp. (Subject) BriaCell Therapeutics (Subject) CVI Investments, Inc. (Filed by)
| Form SC 13G | |
09/12/2024 3:25 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2024 7:50 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Is Elon's empire crumbling? (Ad) The Tesla Shock Nobody Sees Coming
While headlines scream "Tesla is doomed"...
Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs.
One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd. Click here to see the Tesla shock that could blindside everyone. |
09/11/2024 7:50 AM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/23/2024 4:00 PM | BriaCell Therapeutics Corp. (Filer) BriaCell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |